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Abstract
The P2X7 receptor is expressed on T cells, however knowledge of its presence and function on human
CD4+ and CD8+ subsets is limited. Immunolabeling with an anti-human P2X7 monoclonal antibody and
flow cytometry demonstrated that P2X7 is present on the cell-surface of peripheral blood CD4+ and CD8+
T cells. Time-resolved flow cytometry demonstrated that extracellular ATP induced ethidium+ uptake into
both T cell subsets. Flow cytometric measurements also demonstrated that ATP induced the rapid loss of
CD62L (L-selectin) from CD4+ and CD8+ T cells. ATP-induced ethidium+ uptake and CD62L shedding
were dramatically impaired in CD4+ and CD8+ T cells homozygous for the Glu496Ala loss-of-function
single nucleotide polymorphism in the P2RX7 gene, demonstrating that both processes were a result of
P2X7 activation. In summary, these results show that both human CD4+ and CD8+ T cells express P2X7
receptors, and that ATP activation of this receptor can lead to the rapid shedding of CD62L from these
cells.
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The P2X7 receptor is expressed on T cells, however knowledge of its presence and function on human CD4 + and
CD8+ subsets is limited. Immunolabeling with an anti-human P2X7 monoclonal antibody and flow cytometry
demonstrated that P2X7 is present on the cell-surface of peripheral blood CD4+ and CD8+ T cells. Time-resolved flow
cytometry demonstrated that extracellular ATP induced ethidium + uptake into both T cell subsets. Flow cytometric
measurements also demonstrated that ATP induced the rapid loss of CD62L (L-selectin) from CD4+ and CD8+ T cells.
ATP-induced ethidium+ uptake and CD62L shedding were dramatically impaired in CD4 + and CD8+ T cells
homozygous for the Glu496Ala loss-of-function single nucleotide polymorphism in the P2RX7 gene, demonstrating that
both processes were a result of P2X7 activation. In summary, these results show that both human CD4 + and CD8+ T
cells express P2X7 receptors, and that ATP activation of this receptor can lead to the rapid shedding of CD62L from
these cells.
Keywords: T cell; T lymphocyte; purinergic receptor; damage-associated molecular pattern receptor; extracellular ATP;
CD62L; L-selectin
Abbreviations: ATP, adenosine 5’-triphosphate; FITC, fluorescein isothiocyanate; IL-6R, interleukin-6 receptor; mAb,
monoclonal antibody; PE, R-phycoerythrin; SEM, standard error of the mean; SNP, single nucleotide polymorphism
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Introduction
CD62L (L-selectin) is a member of the selectin family
of cell adhesion molecules, and plays important roles in
the recruitment and migration of leukocytes to lymphoid
tissues and sites of inflammation [1]. CD62L directs the
entry of naïve and central memory T cells to lymph nodes
to promote immune responses [2]. Moreover, CD62L can
regulate the migration of certain T cell subsets to sites of
cutaneous inflammation [3], as well as to nasal- and gutassociated lymphoid tissues to promote allergy [4] and
gastrointestinal inflammation [5], respectively. The
expression of CD62L is regulated by a number of

mechanisms including proteolytic cleavage from the cell
surface, which can limit T cell migration and activation
[6]
. However, the signaling mechanisms involved in
CD62L shedding have not been fully elucidated.
Extracellular adenosine 5’-triphosphate (ATP) is a
damage-associated molecular pattern, which mediates its
effects through the activation of the P2X7 receptor, a
trimeric ATP-gated cation channel [7]. P2X7 activation by
extracellular ATP causes the flux of K+, Na+ and Ca2+, as
well as the uptake of organic cations including ethidium+
[7]
. The relative amount of P2X7 function however varies
between humans due to a number of single nucleotide
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polymorphisms (SNPs) in the P2RX7 gene that code for
P2X7 variants with a loss or gain of function [8]. One of
the most common P2X7 SNPs is rs3751143, which codes
for a glutamic acid to alanine substitution at amino acid
496 (Glu496Ala) and leads to a near-complete loss of
receptor function in homozygous dosage [9]. P2X7 is
present on mononuclear leukocytes including T cells
from various species [10-12]. P2X7 activation on T cells
mediates several cell signaling events including the
shedding of cell-surface CD62L [13,14]. However,
knowledge about the presence and function of P2X7 on
human CD4+ and CD8+ T cells is limited. Using
peripheral blood lymphocytes from subjects wild-type,
heterozygous and homozygous for the Glu496Ala SNP,
the current study aimed to investigate the presence of
functional P2X7 receptors on human CD4+ and CD8+ T
cells, and whether activation of this receptor results in
CD62L shedding from these T cell subsets.
Materials and methods
Lymphocytes. Peripheral blood was collected from
healthy human volunteers who were previously identified
as wild-type, heterozygous or homozygous for the
Glu496Ala SNP in the P2RX7 gene [15]. Peripheral blood
mononuclear cells were separated by gradient
centrifugation using Ficoll-Paque PLUS (Amersham
Biosciences, Uppsala, Sweden) and cultured in RPMI1640 medium (Sigma, St. Louis, MO) containing 10%
foetal calf serum, 1 mM L-glutamine, 0.1 mM nonessential amino acids, 5.5 x 10-2 mM 2-mercaptoethanol,

Measurement of ATP-induced ethidium+ uptake. ATPinduced ethidium+ uptake into lymphocytes was
measured as described [16]
bromide (Sigma Chemical Co., St. Louis, MO) was
added to lymphocytes (2x106/mL), pre-labeled with
FITC-conjugated anti-CD4 or CD8 mAb, in KCl medium
(150 mM KCl, 5 mM D-glucose, 0.1% (w/v) bovine
serum albumin, 10 mM HEPES, pH 7.4) at 37oC,
followed by the addition of 1 mM ATP (Sigma Chemical
Co.) 40 s later. Data was acquired at 5 s intervals for
either CD4+ or CD8+ cells within the lymphocyte gate
(selected using forward and side scatter) and analysed
using
WinMDI
software
(version
2.7;
+
http://www.scripps.edu). ATP-induced ethidium uptake
was quantitated as the difference in arbitrary units of area
under the uptake curves in the presence and absence of
ATP during the first 5 min of incubation.
Measurement of ATP-induced CD62L shedding. ATPinduced CD62L shedding from lymphocytes was
measured as described [13]. Lymphocytes (2x106/mL)
were incubated for up to 15 min in KCl medium at 37oC
in the presence or absence of 0.5 mM ATP with the
incubations stopped by adding two volumes of cold
MgCl2 medium (145 mM NaCl, 5 mM KCl, 10 mM
MgCl2, 10 mM HEPES, pH 7.4). Cells were washed and
the mean fluorescence intensity of CD62L surface
expression determined by flow cytometry as above.
Results are presented as the percentage of CD62L
expression in the presence of ATP compared to CD62L
expression in the absence of ATP (control).

Auckland, New Zealand) for 2 hours at 37oC and 95%
air/5% CO2. The non-adherent cells were collected to
obtain lymphocytes. Blood was collected and used in
accordance with institutional guidelines and approval
from the Wentworth Area Health Service (Penrith,
Australia) and University of Sydney (Sydney, Australia)
Ethics Committees.

Data presentation and statistical analyses. Data is
expressed as mean and standard error of the mean (SEM).
Differences between groups were compared by the Oneway ANOVA (using Tukey's multiple comparison test)
using Prism 5 (GraphPad Software, San Diego, CA) with
P < 0.05 considered significant.

Immunolabeling and flow cytometry. Fluorescein
isothiocyanate (FITC)- and R-phycoerythrin (PE)conjugated anti-CD4, CD8 and CD62L monoclonal
antibodies (mAb) were from BD Biosciences (San Diego,
CA). PE-Cy5-conjugated anti-CD3 mAb was from Dako
(Carpinteria, CA). FITC-conjugated anti-P2X7 mAb
(clone L4) was prepared as described [11]. Lymphocytes
(1x106) were labeled with fluorochrome-conjugated mAb
in the presence of 10% human AB serum for 20 min and
washed. CD3+CD4+ or CD3+CD8+ cells within the
lymphocyte gate (gated by forward and side scatter) were
analysed for P2X7 or CD62L expression using a
FACSCalibur flow cytometer and Cell Quest software
(BD Biosciences).

Labeling of CD4+ and CD8+ T cells, from normal
human subjects, with anti-P2X7 mAb showed that both
cell subtypes expressed P2X7 on the cell surface (Fig. 1).
Consistent with previous findings for T and B cells [9] the
amount of cell-surface P2X7 between either T cell subset
from subjects wild-type, heterozygous or homozygous for
the Glu496Ala SNP was similar (Table 1). The amount of
cell-surface P2X7 between CD4+ and CD8+ T cells was
also similar. The similar but low amounts of P2X7 on
both T cell subsets is consistent with the relatively low
amount of P2X7 observed previously on CD3+ T cells
[11]
.

Results and discussion

Extracellular ATP induced ethidium+ uptake into
CD4+ and CD8+ T cells from wild-type subjects with
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Figure 2. P2X7 activation mediates ATP-induced ethidium+
uptake into human CD4+ and CD8+ T cells. Lymphocytes wildtype, heterozygous or homozygous for the Glu496Ala SNP were prelabeled with FITC-conjugated CD4 or CD8 mAb. Cells were
suspended in KCl medium (37oC) and ethidium+ was added,
followed by the addition of 1 mM ATP 40 s later (arrow). Mean
fluorescence intensity (MFI) of ethidium + uptake was acquired at 5 s
intervals by flow cytometry. Ethidium+ uptake in the absence of ATP
was minimal and similar between subsets and subjects (results not
shown). Representative data from six (wild-type) or three
(heterozygous or homozygous) subjects is shown.

Figure 1. P2X7 is present on human CD4+ and CD8+ T cells.
Lymphocytes wild-type, heterozygous or homozygous for the
Glu496Ala SNP were labeled with FITC-conjugated P2X7 (black
line) or isotype control (grey line) mAb, PE-conjugated CD4 or CD8
mAb, and PE-Cy5-conjugated CD3 mAb, and analyzed by flow
cytometry. Representative data from six (wild-type) or three
(heterozygous or homozygous) subjects is shown.

mean arbitrary units of uptake (SEM) of 1664 (510) and
3478 (1263), respectively (n = 6; Fig. 2). ATP also
induced ethidium+ uptake into CD4+ and CD8+ T cells
from heterozygous subjects with mean arbitrary units of
uptake (SEM) of 509 (356) and 1155 (391), respectively
(n = 3), which on average was one-third lower than that
observed for wild-type CD4+ and CD8+ T cells (Fig. 2).
In contrast, ATP induced only minimal ethidium+ uptake
into CD4+ and CD8+ T cells from homozygous subjects
with mean arbitrary units of uptake (SEM) of 47 (23) and
295 (105), respectively (n = 3; Fig. 2). Comparison of
CD4+ and CD8+ T cells showed that ATP-induced
ethidium+ uptake tended to be higher in CD8+ T cells
than in CD4+ T cells for each genotype, but this
difference did not reach statistical significance. However
comparison between the subsets is complicated by the
ability to gate only FITC-labeled CD4+ or CD8+ T cells,
as ethidium+ interferes with the far-red channel and

prevented the use of PE-Cy5-conjugated CD3 mAb on
our single laser flow cytometer. Natural killer cells,
which have higher P2X7 function than T cells [11], can
also express CD8 [17], and thus would have been included
in the CD8+ gate to potentially contribute to the greater
P2X7 function of CD8+ T cells compared to CD4+ T
cells. Nevertheless immunolabeling with an anti-P2X7
mAb and measurements of ATP-induced ethidium+
uptake demonstrate that both human CD4+ and CD8+ T
cells express P2X7.
Extracellular ATP also induced a rapid loss of CD62L
from the cell-surface of CD4+ and CD8+ T cells from
wild-type subjects in a near-identical and time-dependent
fashion (Fig. 3). In contrast to ATP-induced ethidium+
uptake (Fig. 2), ATP induced a loss of CD62L from
CD4+ and CD8+ T cells from heterozygous subjects that
was only marginally slower than that observed for wildtype T cells (Fig. 3). This rate of loss of cell-surface
CD62L from CD4+ and CD8+ T cells from subjects of
either genotype was similar to that previously reported
for human CD4+ T cells [18], and for human B and T cells
[13]
. In contrast, the ATP-induced loss of CD62L was
dramatically impaired from homozygous T cells
compared to wild-type or heterozygous T cells (Fig. 3).
Although the shedding of CD62L into the extracellular
medium was not directly assessed, ELISA measurements
of soluble CD62L have confirmed that P2X7 activation
induces the shedding of CD62L from human B cells [13].
Collectively, the above data demonstrates that P2X7
activation induces the rapid shedding of CD62L from
both human CD4+ and CD8+ T cells.
The cell signaling events that mediate P2X7-induced
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Table 1. P2X7 expression on human CD4+ and CD8+ T cells.

Wild-type
Heterozygote
Homozygote

CD4+ T cellsa
MFI
Percent
4.9 (0.5)
29.3 (1.4)
4.0 (1.1)
27.5 (4.8)
4.2 (0.4)
24.1 (2.1)

CD8+ T cellsa
MFI
Percent
4.8 (0.6)
24.4 (1.6)
4.0 (0.9)
22.5 (4.3)
4.5 (0.6)
22.6 (3.6)

a

Lymphocytes wild-type, heterozygous or homozygous for the Glu496Ala SNP were labeled with FITC-conjugated
P2X7 or isotype control mAb, PE-conjugated CD4 or PE-conjugated CD8 mAb, and PE-Cy5-conjugated CD3 mAb.
The mean fluorescence intensity (MFI) of P2X7 expression or percent of P2X7 positive cells (Percent) was determined
by flow cytometry. Data is represented as mean (SEM); n = 6 (wild-type) or n = 3 (heterozygous or homozygous)
subjects.

shedding of CD62L from T cells remain to be
determined. Human P2X7 activation induces the rapid
shedding of CD23 and CXCL16 from malignant B cells
[19-21]
, as well as the shedding of the interleukin-6
receptor (IL-6R) from human epithelial cells or murine
fibroblasts co-transfected with human P2X7 and human
IL-6R [22]. Human P2X7-induced CD23, CXCL16 and
IL-6R shedding is primarily mediated by ADAM10 [21,22],
however it is likely that ADAM17 is the principle
sheddase involved in P2X7-induced CD62L shedding
from human CD4+ and CD8+ T cells. It has previously
been shown that P2X7-induced CD62L and CD23
shedding from malignant B cells is mediated by different
metalloproteases [20], and that ADAM17 is the principle
sheddase for both calcium- and ATP-induced CD62L
shedding from murine B cells [23]. Furthermore, P2X7induced CD62L shedding from malignant B cells is
impaired by the zinc-metalloprotease inhibitor, Ro 319790, [20] which indirectly supports a role for ADAM17
in this process.

Despite the known involvement of ADAM10 and
ADAM17 in P2X7-induced shedding of cell-surface
molecules, the cell signaling mechanisms involved in this
process have remained far more elusive. Attempts using
inhibitors of candidate enzymes predicted to mediate
P2X7-induced CD62L and CD23 shedding have failed to
show a role for various intracellular signaling enzymes
[13,18,24]
. In contrast, use of 4,4’-diisothiocyanatosilbene2,2’-disulphonic acid, an inhibitor of phosphatidylserine
translocation, indicates that P2X7-induced CD62L
shedding from murine CD4+CD45RBhigh T cells is
dependent on phosphatidylserine exposure [25], although
the precise mechanism involved in this signaling axis
remains to be determined. Moreover, mitochondrial but
not NADPH oxidase superoxide formation has been
shown to enhance P2X7-induced CD62L shedding from
human CD4+ T cells, but despite this observation P2X7induced CD62L shedding appears to be independent of
mitochondrial superoxide formation [18]. Thus, further
studies are required to ascertain the cell signaling
pathways involved in P2X7-induced metalloprotease
activation and the subsequent shedding of cell-surface
molecules including CD62L. Further studies are also
required to determine the physiological significance of
P2X7-induced CD62L shedding in inflammation.
In summary, the current results show that both human
CD4+ and CD8+ T cells express P2X7, and that activation
of this receptor by extracellular ATP can lead to the rapid
shedding of CD62L from these cells.

Figure 3. P2X7 activation mediates ATP-induced CD62L
shedding from human CD4+ and CD8+ T cells. Lymphocytes wildtype, heterozygous or homozygous subjects for the Glu496Ala SNP
were suspended in KCl medium (37oC), and incubated for up to 15
min in the absence or presence of 0.5 mM ATP. Incubations were
terminated and the expression of CD62L on CD3+CD4+ and
CD3+CD8+ T cells measured by flow cytometry. Results are shown
as the mean percentage loss of CD62L (SEM); n = 6 (wild-type) or n
= 3 (heterozygous or homozygous). **P < 0.01 or ***P < 0.001 to
corresponding wild-type T cells subset.
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